BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30463940)

  • 1. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
    Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
    J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.
    Bhargavan B; Chhunchha B; Fatma N; Kubo E; Kumar A; Singh DP
    Epigenetics; 2013 Mar; 8(3):268-80. PubMed ID: 23386123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1.
    Yang PM; Lin PJ; Chen CC
    Epigenetics; 2012 Apr; 7(4):390-9. PubMed ID: 22419072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells.
    Wong CY; Wuriyanghan H; Xie Y; Lin MF; Abel PW; Tu Y
    J Biol Chem; 2011 Jul; 286(29):25813-22. PubMed ID: 21636851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
    Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
    Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.
    Gan Y; Shen YH; Wang J; Wang X; Utama B; Wang J; Wang XL
    J Biol Chem; 2005 Apr; 280(16):16467-75. PubMed ID: 15722551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma.
    Yu Q; Liu Y; Zheng X; Zhu Q; Shen Z; Wang H; He H; Lin N; Jiang H; Yu L; Zeng S
    Drug Metab Dispos; 2017 Jan; 45(1):109-117. PubMed ID: 27821436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of
    Zhu Q; Yu L; Qin Z; Chen L; Hu H; Zheng X; Zeng S
    Epigenetics; 2019 Aug; 14(8):791-803. PubMed ID: 31088315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.
    Kumar P; Tripathi S; Pandey KN
    J Biol Chem; 2014 Mar; 289(10):6991-7002. PubMed ID: 24451378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
    Estève PO; Chin HG; Pradhan S
    J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer.
    Kim TW; Lee SJ; Oh BM; Lee H; Uhm TG; Min JK; Park YJ; Yoon SR; Kim BY; Kim JW; Choe YK; Lee HG
    Oncotarget; 2016 Jan; 7(4):4195-209. PubMed ID: 26675260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate activates erythroid-specific 5-aminolevulinate synthase gene through Sp1 elements at its promoter.
    Han L; Zhong Y; Huang B; Han L; Pan L; Xu X; Wang X; Huang B; Lu J
    Blood Cells Mol Dis; 2008; 41(2):148-53. PubMed ID: 18555711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human ZNF312b oncogene is regulated by Sp1 binding to its promoter region through DNA demethylation and histone acetylation in gastric cancer.
    Song IS; Ha GH; Kim JM; Jeong SY; Lee HC; Kim YS; Kim YJ; Kwon TK; Kim NS
    Int J Cancer; 2011 Nov; 129(9):2124-33. PubMed ID: 21170990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancer.
    Li G; Xie Q; Yang Z; Wang L; Zhang X; Zuo B; Zhang S; Yang A; Jia L
    Int J Cancer; 2019 Dec; 145(12):3285-3298. PubMed ID: 31111958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 1 can repress transcription by binding to Sp1.
    Doetzlhofer A; Rotheneder H; Lagger G; Koranda M; Kurtev V; Brosch G; Wintersberger E; Seiser C
    Mol Cell Biol; 1999 Aug; 19(8):5504-11. PubMed ID: 10409740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation.
    Li F; Wu R; Cui X; Zha L; Yu L; Shi H; Xue B
    J Biol Chem; 2016 Feb; 291(9):4523-36. PubMed ID: 26733201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.
    Chen CH; Huang PH; Chu PC; Chen MC; Chou CC; Wang D; Kulp SK; Teng CM; Wang Q; Chen CS
    J Biol Chem; 2011 Mar; 286(12):9968-76. PubMed ID: 21282102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation.
    Miranda-Gonçalves V; Lameirinhas A; Macedo-Silva C; Lobo J; C Dias P; Ferreira V; Henrique R; Jerónimo C
    Cells; 2020 Apr; 9(4):. PubMed ID: 32340156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma.
    Li H; Wang X; Zhang C; Cheng Y; Yu M; Zhao K; Ge W; Cai A; Zhang Y; Han F; Hu Y
    Cancer Lett; 2018 Sep; 432():121-131. PubMed ID: 29890207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.